Literature DB >> 15950179

Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication.

Dennis R LaJeunesse1, Kelly Brooks, Amy L Adamson.   

Abstract

Epstein-Barr virus (EBV) is a human DNA virus that is responsible for the syndrome infectious mononucleosis, and is associated with several forms of cancer. During both lytic and latent viral infection, viral proteins manipulate the host's cellular components to aid in viral replication and maintenance. Here, it is demonstrated that induction of EBV lytic replication results in a dramatic reorganization of mitochondria accompanied by a significant alteration of mitochondrial membrane potential and a rapid and transient increase in the microtubular cytoskeleton. Moreover, we show that expression of the EBV immediate-early genes BZLF1 and BRLF1 contributes to the mitochondrial alteration but not the increase in the microtubule cytoskeleton, suggesting that the mechanism for the observed cytoplasmic restructuring involves a number of coordinated viral and host proteins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950179     DOI: 10.1016/j.bbrc.2005.05.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines.

Authors:  Bochra Gargouri; Jos Van Pelt; Abd El Fatteh El Feki; Hammadi Attia; Saloua Lassoued
Journal:  Mol Cell Biochem       Date:  2008-12-11       Impact factor: 3.396

2.  Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses.

Authors:  Young Bong Choi; Edward William Harhaj
Journal:  Front Biol (Beijing)       Date:  2014-12

Review 3.  The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability.

Authors:  Gerwyn Morris; Michael Berk; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-06-17       Impact factor: 5.590

4.  Modeling early Epstein-Barr virus infection in Drosophila melanogaster: the BZLF1 protein.

Authors:  Amy L Adamson; Natasha Wright; Dennis R LaJeunesse
Journal:  Genetics       Date:  2005-08-03       Impact factor: 4.562

5.  Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.

Authors:  Andreas Wiedmer; Pu Wang; Jing Zhou; Andrew J Rennekamp; Valeria Tiranti; Massimo Zeviani; Paul M Lieberman
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

6.  Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta.

Authors:  Mengmeng Zhao; Asuka Nanbo; David Becnel; Zhiqiang Qin; Gilbert F Morris; Li Li; Zhen Lin
Journal:  J Virol       Date:  2020-10-27       Impact factor: 5.103

Review 7.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

8.  Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines.

Authors:  Bochra Gargouri; Rihab Nasr; Malek Mseddi; Riadh Benmansour; Saloua Lassoued
Journal:  Lipids Health Dis       Date:  2011-07-01       Impact factor: 3.876

Review 9.  Mitochondrial Proteins Coded by Human Tumor Viruses.

Authors:  Ilaria Cavallari; Gloria Scattolin; Micol Silic-Benussi; Vittoria Raimondi; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Front Microbiol       Date:  2018-02-06       Impact factor: 5.640

10.  Reactive oxygen species mediate Epstein-Barr virus reactivation by N-methyl-N'-nitro-N-nitrosoguanidine.

Authors:  Sheng-Yen Huang; Chih-Yeu Fang; Chung-Chun Wu; Ching-Hwa Tsai; Su-Fang Lin; Jen-Yang Chen
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.